MARKET

QNCX

QNCX

Quince
NASDAQ
0.9843
-0.0157
-1.57%
Opening 13:04 06/09 EDT
OPEN
0.9900
PREV CLOSE
1.000
HIGH
1.010
LOW
0.9550
VOLUME
647.74K
TURNOVER
--
52 WEEK HIGH
45.50
52 WEEK LOW
0.7900
MARKET CAP
16.04M
P/E (TTM)
-0.1081
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QNCX last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at QNCX last week (0525-0529)?
Weekly Report · 06/01 09:43
Weekly Report: what happened at QNCX last week (0518-0522)?
Weekly Report · 05/25 09:45
Quince Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
TipRanks · 05/21 23:41
Quince Therapeutics regains Nasdaq listing compliance after equity rises to $15.67 million
PUBT · 05/21 21:07
Quince Therapeutics Closes Orphai Deal and Secures Funding
TipRanks · 05/18 14:40
UPDATE - QUINCE THERAPEUTICS ANNOUNCES CLINICALLY MEANINGFUL IMPROVEMENTS ACROSS FUNCTIONAL, HEMODYNAMIC AND BIOMARKER MEASURES IN PHASE 2 STUDY IN PAH AND PH-ILD
Reuters · 05/18 14:21
Quince Therapeutics announces LAM-001 data
TipRanks · 05/18 13:41
More
About QNCX
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. Its proprietary autologous intracellular drug encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The Company’s Phase III lead asset, eDSP, leverages its AIDE technology to encapsulate dexamethasone sodium phosphate (DSP) into a patient’s own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, Ataxia-Telangiectasia (A-T). Its AIDE technology is designed to allow for the chronic administration of drugs that have limitations due to toxicity, poor biodistribution, suboptimal pharmacokinetics, or immune response. The AIDE technology platform delivers a variety of therapeutics, ranging from small to large molecules drugs and biologics.

Webull offers Quince Therapeutics Inc stock information, including NASDAQ: QNCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNCX stock methods without spending real money on the virtual paper trading platform.